Related Experiment Video
Updated: Sep 11, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Factors associated with symptom relief in patients with irritable bowel syndrome: a retrospective cohort study
Ming Zhao1, Rui Luo2, Yang Shen2
1Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Background:
Symptom relief in irritable bowel syndrome (IBS) varies widely, influenced by demographic, clinical, and psychosocial factors. Identifying factors associated with symptom relief can enhance management strategies for IBS patients.
Objective:
This study aimed to examine factors associated with symptom relief in a cohort of IBS patients, focusing on the role of demographic, lifestyle, psychological, and physiological characteristics.
Methods:
We conducted a retrospective cohort study of 278 IBS patients treated at a tertiary hospital. Demographic data, IBS subtype, symptom severity, lifestyle factors, and psychological variables (anxiety, depression, stress) were collected. Symptom relief, defined as a 50% reduction in baseline symptom severity, was the primary outcome. Univariate and multivariate logistic regression analyses were performed to identify factors associated with symptom relief, with subgroup analyses examining key demographic and lifestyle factors.
Results:
In multivariate analysis, symptom severity (OR = 1.20, 95% CI: 1.05-1.37, p = 0.008), daily exercise (OR = 1.50, 95% CI: 1.01-2.24, p = 0.04), and low depression scores (OR = 0.93, 95% CI: 0.89-0.98, p = 0.003) remained independent predictors of symptom relief.
Conclusion:
Symptom severity, daily exercise, and lower depression levels are independently associated with symptom relief in IBS patients, highlighting the importance of lifestyle modifications and mental health support. These findings suggest that physical activity and psychological well-being were associated with symptom relief, highlighting their potential relevance in holistic IBS management strategies.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
06:04Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...